Shin Nippon Biomedical Laboratories (SNBL)
Shin Nippon Biomedical Laboratories (SNBL), was founded in Kagoshima as Japan’s first contract research organization in 1957.
Launch date
Employees
Market cap
€331m
Enterprise valuation
€440m (Public information from Sep 2024)
Share price
JPY1189 2395.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 14.6b | 15.1b | 17.7b | 25.1b | 26.5b | 3.7b | 4.2b |
| % growth | - | 4 % | 17 % | 41 % | 5 % | (86 %) | 13 % |
| EBITDA | 4.2b | 5.0b | 8.7b | 10.9b | 9.0b | - | - |
| % EBITDA margin | 29 % | 33 % | 49 % | 44 % | 34 % | - | - |
| Profit | 2.6b | 3.7b | 7.1b | 6.1b | 5.5b | - | - |
| % profit margin | 18 % | 24 % | 40 % | 24 % | 21 % | - | - |
| EV / revenue | 3.1x | 3.4x | 1.9x | 0.9x | 2.9x | - | - |
| EV / EBITDA | 10.7x | 10.1x | 3.9x | 2.0x | 8.4x | - | - |
| R&D budget | 401m | 392m | 425m | 683m | 1.7b | - | - |
| R&D % of revenue | 3 % | 3 % | 2 % | 3 % | 7 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Shin Nippon Biomedical Laboratories (SNBL)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Shin Nippon Biomedical Laboratories (SNBL)
Edit
exited
ACQUISITION by Shin Nippon Biomedical Laboratories (SNBL) Apr 2023
exited